Inclacumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | selectin P |
Clinical data | |
Synonyms | LC1004-002 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
KEGG | |
Chemical and physical data | |
Formula | C6452H9930N1730O2024S42 |
Molar mass | 145.5 kDa |
Inclacumab (LC1004-002) (INN) is a human monoclonal antibody designed for the treatment of cardiovascular disease.[1][2]
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.